TRIAZOLE ALS KV3 INHIBITOREN

Patent europeic · EP2852589 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2852589
Numer da la dumonda
EP13725447
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-05-2013
Publitgà
01-04-2015
Concedì
28-04-2021
Stritgà
22-12-2021
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 405/14 (2006.01)
C07D 401/04 (2006.01)
C07D 249/12 (2006.01)
A61K 31/4196 (2006.01)
A61P 25/00 (2006.01)
Prioritad
GB 201209013 22.05.2012
GB 201209019 22.05.2012
GB 201209020 22.05.2012
US 201261702337 P 18.09.2012
GB 201222393 12.12.2012
Dumonda PCT
PCT/GB2013/051347 22.05.2013
Publicaziun PCT
WO2013/175215 28.11.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-03-2022

    Midada

    Published in Swissreg on 09.03.2022

  2. 22-12-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.12.2021

  3. 23-06-2021

    Owner

    Owner
    Autifony Therapeutics Limited, B205 Imperial College Incubator, Level 1 Bessemer Building, Imperial College, London SW7 2AZ, United Kingdom → Autifony Therapeutics Limited, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX, United Kingdom

    Published in Swissreg on 23.06.2021

  4. 28-04-2021

    Concedì

    Published in Swissreg on 28.04.2021

Partidas

Inventur

HAMPRECHT, Dieter

I-37135 Verona, IT

MARASCO, Agostino

I-37135 Verona, IT

DECOR, Anne

I-37135 Verona, IT

ALVARO, Giuseppe

I-37135 Verona, IT

DAMBRUOSO, Paolo

I-37135 Verona, IT

TOMMASI, Simona

I-37135 Verona, IT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.